Spectral MD Holdings, Ltd. Logo

Spectral MD Holdings, Ltd.

SMD.L

(0.5)
Stock Price

58,00 GBp

-15.56% ROA

-22.77% ROE

-35.47x PER

Market Cap.

104.297.506,04 GBp

10.01% DER

0% Yield

-11.48% NPM

Spectral MD Holdings, Ltd. Stock Analysis

Spectral MD Holdings, Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Spectral MD Holdings, Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (12%), which means it has a small amount of debt compared to the ownership it holds

2 ROE

The stock's ROE indicates a negative return (-32.45%) on shareholders' equity, suggesting poor financial performance.

3 ROA

The stock's ROA (-26.14%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

4 PBV

The stock's elevated P/BV ratio (11.31x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's lack of dividends in the past three years may concern investors seeking regular income.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Spectral MD Holdings, Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Spectral MD Holdings, Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Spectral MD Holdings, Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Spectral MD Holdings, Ltd. Revenue
Year Revenue Growth
2018 7.251.276
2019 5.848.489 -23.99%
2020 17.300.884 66.2%
2021 15.167.827 -14.06%
2022 25.368.000 40.21%
2023 20.312.000 -24.89%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Spectral MD Holdings, Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Spectral MD Holdings, Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 3.770.216
2019 5.564.275 32.24%
2020 6.537.687 14.89%
2021 11.326.513 42.28%
2022 13.484.000 16%
2023 23.272.000 42.06%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Spectral MD Holdings, Ltd. EBITDA
Year EBITDA Growth
2018 -462.743
2019 -3.041.211 84.78%
2020 1.449.196 309.86%
2021 -4.532.243 131.98%
2022 -2.283.000 -98.52%
2023 -13.912.000 83.59%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Spectral MD Holdings, Ltd. Gross Profit
Year Gross Profit Growth
2018 3.302.983
2019 2.522.982 -30.92%
2020 7.986.457 68.41%
2021 6.981.129 -14.4%
2022 10.837.000 35.58%
2023 8.724.000 -24.22%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Spectral MD Holdings, Ltd. Net Profit
Year Net Profit Growth
2018 -498.831
2019 -3.107.170 83.95%
2020 1.234.731 351.65%
2021 -4.155.004 129.72%
2022 -2.912.000 -42.69%
2023 -14.436.000 79.83%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Spectral MD Holdings, Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Spectral MD Holdings, Ltd. Free Cashflow
Year Free Cashflow Growth
2018 -337.523
2019 -1.592.043 78.8%
2020 3.819.572 141.68%
2021 -2.925.893 230.54%
2022 -1.162.000 -151.8%
2023 -3.754.000 69.05%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Spectral MD Holdings, Ltd. Operating Cashflow
Year Operating Cashflow Growth
2018 -337.523
2019 -1.592.043 78.8%
2020 3.819.572 141.68%
2021 -2.918.677 230.87%
2022 -1.162.000 -151.18%
2023 -3.754.000 69.05%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Spectral MD Holdings, Ltd. Capital Expenditure
Year Capital Expenditure Growth
2018 0
2019 0 0%
2020 0 0%
2021 7.216 100%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Spectral MD Holdings, Ltd. Equity
Year Equity Growth
2018 -520.845
2019 -2.721.057 80.86%
2020 1.135.565 339.62%
2021 13.585.361 91.64%
2022 11.996.000 -13.25%
2023 8.687.000 -38.09%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Spectral MD Holdings, Ltd. Assets
Year Assets Growth
2018 2.572.812
2019 1.680.246 -53.12%
2020 7.939.464 78.84%
2021 18.484.687 57.05%
2022 18.716.000 1.24%
2023 14.183.000 -31.96%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Spectral MD Holdings, Ltd. Liabilities
Year Liabilities Growth
2018 3.093.657
2019 4.401.303 29.71%
2020 6.803.899 35.31%
2021 4.899.326 -38.87%
2022 6.720.000 27.09%
2023 5.496.000 -22.27%

Spectral MD Holdings, Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.19
Net Income per Share
-0.02
Price to Earning Ratio
-35.47x
Price To Sales Ratio
4.11x
POCF Ratio
-88.89
PFCF Ratio
-89.76
Price to Book Ratio
8.61
EV to Sales
3.6
EV Over EBITDA
-40
EV to Operating CashFlow
-78.59
EV to FreeCashFlow
-78.59
Earnings Yield
-0.03
FreeCashFlow Yield
-0.01
Market Cap
0,10 Bil.
Enterprise Value
0,09 Bil.
Graham Number
0.21
Graham NetNet
0.05

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
0.4
ROE
-0.23
Return On Assets
-0.16
Return On Capital Employed
-0.21
Net Income per EBT
1.04
EBT Per Ebit
1.06
Ebit per Revenue
-0.1
Effective Tax Rate
-0.04

Margins

Sales, General, & Administrative to Revenue
0.53
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.05
Gross Profit Margin
0.43
Operating Profit Margin
-0.1
Pretax Profit Margin
-0.11
Net Profit Margin
-0.11

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.19
Return on Tangible Assets
-0.16
Days Sales Outstanding
0
Days Payables Outstanding
69.3
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
5.27
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,10
Book Value per Share
0,09
Tangible Book Value per Share
0.09
Shareholders Equity per Share
0.09
Interest Debt per Share
0.01
Debt to Equity
0.1
Debt to Assets
0.06
Net Debt to EBITDA
5.68
Current Ratio
2.77
Tangible Asset Value
0,01 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.1
Working Capital
0,01 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.01

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Spectral MD Holdings, Ltd. Dividends
Year Dividends Growth

Spectral MD Holdings, Ltd. Profile

About Spectral MD Holdings, Ltd.

Spectral MD Holdings, Ltd. develops AI algorithms and optical technology for faster treatment decisions in wound care. It offers DeepView wound imaging solution, an AI technology and multispectral imaging system that provides healing assessments for burn wounds and diabetic foot ulcers. The company was incorporated in 2020 and is headquartered in Dallas, Texas.

CEO
Mr. Wensheng Fan
Employee
77
Address
2515 Mckinney Avenue
Dallas, 75201

Spectral MD Holdings, Ltd. Executives & BODs

Spectral MD Holdings, Ltd. Executives & BODs
# Name Age
1 Dr. So-Jin Holohan Ph.D.
Head of UK/EU Clinical Research
70
2 Mr. Wensheng Fan
Co-Founder, Chief Executive Officer & Executive Director
70
3 Mr. Nils Windler
Chief Financial Officer
70
4 Dr. Niko Pagoulatos Ph.D.
Chief Operating Officer
70
5 Dr. Jeffrey Thatcher Ph.D.
Chief Scientist
70
6 Mr. Vincent S. Capone
Gen. Counsel & Corporation Sec.
70
7 Ms. Christine Marks
Vice President of Marketing & Commercialization
70
8 Dr. Jeffrey Carter M.D.
Chief Medical Consultant
70
9 David Bronson
Financial Controller
70

Spectral MD Holdings, Ltd. Competitors

Belluscura plc Logo
Belluscura plc

BELL.L

(0.8)
ActiveOps Plc Logo
ActiveOps Plc

AOM.L

(0.5)
Poolbeg Pharma PLC Logo
Poolbeg Pharma PLC

POLB.L

(1.0)